Title
Society of Nuclear Medicine and Molecular Imaging (SNMMI)
Go Home
Category
Description
Address
Phone Number
+1 609-831-2326 (US) | Message me
Site Icon

	Society of Nuclear Medicine and Molecular Imaging (SNMMI)
Page Views
0
Share
Update Time
2022-05-05 20:39:39

"I love Society of Nuclear Medicine and Molecular Imaging (SNMMI) "

www.snmmi.org VS www.gqak.com

2022-05-05 20:39:39

Donate |Join/Renew |Store |View Cart |Log In #header_search { float: right; margin: 0.21em 0 0 0; padding: 0; clear: right; width: 246px; } #header_search .searchbox { background-image: url(//s3.amazonaws.com/rdcms-snmmi/files/production/public/PageLayoutImages/searchbg_snmmi.png); width: 218px; height: 31px; float: left; padding: 0; font-size: 12px; font-family: Verdana, Arial, sans-serif; color: #222222; text-indent: 3.1em; border: 0; outline: none; line-height: 31px; position: relative; -webkit-border-radius: 0 !important; -webkit-appearance: none; } #header_search .searchbtn { width: 28px; height: 31px; border: 0; float: right; cursor: pointer; -webkit-border-radius: 0 !important; -webkit-appearance: none; } #header_search_options { width: 218px; float: right; display: block; clear: right; } #header_search_options .searchDropDown { width: 187px; visibility: hidden; float: right; display: block; font-family: Verdana, Arial, sans-serif; font-size: 10px; background: #F1F1F1; white-space: nowrap; padding: 0px; margin: 0px 30px 2px 0px; position: relative; border: 1px solid; border-bottom-right-radius: 5px; border-bottom-left-radius: 5px; } #header_search_options .snmmiSearchOption { display: block; padding: 5px 8px 5px 8px; } #header_search_options .snmmiSearchOption:hover { cursor: pointer; background-color: #C8C8C8; } #header_search_options .cecitySearchOption { display: block; border-top: 1px solid; padding: 5px 8px 5px 8px; } #header_search_options .cecitySearchOption:hover { cursor: pointer; background-color: #C8C8C8; border-bottom-right-radius: 5px; border-bottom-left-radius: 5px; } Value Initiative | Physicians | Technologists | Scientists | Residents | Healthcare Provider | Patients NEWS & PUBLICATIONS News and Media Newsletters Journals Books MEMBERSHIP Join/Renew Benefits Categories Download a Member Application Grants, Awards, and Scholarships Access the Phantom Analysis Toolkit Membership Directory Chapters Centers of Excellence Councils Member Spotlight Women in Nuclear Medicine SNMMI Fellow Council and Center Internships EDUCATION 2022 Annual Meeting Call for Abstracts Webinars MEETINGS & EVENTS Calendar of Events Webinars 2022 Annual Meeting 2022 Therapeutics Conference 2022 Mid-Winter Meeting Nuclear Medicine & Molecular Imaging Week ADVOCACY Coding & Reimbursement Legislative Efforts Government Relations News Radiopharmaceutical Supply News USP 825 Technologist State Issues Position Statements Coalition for PET Drugs FDA PET Drug Manufacturing Q&A EVIDENCE & QUALITY Clinical Guidelines and AUC Quality Practice Resources Dose Optimization About Quality & Practice Dosimetry RESEARCH Clinical Trials Network Radiopharmaceutical Therapy Central Radiopharmaceutical Therapy Centers of Excellence Preclinical Imaging Nuclear Medicine Clinical Trial Group, LLC Research: Learn More ABOUT SNMMI Strategic Plan Bylaws & Procedures Governance - SNMMI Governance - SNMMI-TS History Grants, Awards, and Scholarships Career Center About Nuclear Medicine & Molecular Imaging International Collaboration Outreach Support SNMMI Contact Us Novartis Announces Temporary Halt in Production of Lutathera and PluvictoToday Novartis announced it will suspend production of Lutathera and Pluvicto at its radioligand therapy production sites in Ivrea, Italy, and Milburn, New Jersey, temporarily affecting commercial and clinical trial supply. Don't Miss the SNMMI 2022 Annual Meeting!View this year's scientific and continuing education program—featuring more than 130 scientific and CE sessions—and prepare yourself for the SNMMI 2022 Annual Meeting, June 11-14 in Vancouver, BC. In-person and virtual registration options available. Register now! Active Brown Adipose Tissue Protects Against “Pre-Prediabetes”JNM study suggests that active brown fat is recruited to counteract “pre-prediabetic” states, potentially serving as a first-line protective mechanism against very early metabolic or hormonal abnormalities.SNMMI and Partners Request a Hearing for the FIND ActThis week, SNMMI and more than 70 organizations sent a letter to House Energy and Commerce and Ways and Means Committee Leadership requesting a hearing on the Facilitating Innovative Nuclear Diagnostics (FIND) Act.This Month in JNM In May JNM: Translational Cancer Research Priorities…Clinical fluorescence imaging guideline…Total-body PET and the future…CE: Radiotracers in cardiovascular imaging…Signaling that drives 18F-FDG PET… Featured: CD8-targeted PET imaging of tumor-infiltrating T cells in patients with cancer…and more. SNMMI NEWS May 5, 2022 — Novartis Announces Temporary Halt in Production of Lutathera and Pluvicto On May 5, Novartis announced that it will temporarily suspend production of Lutathera and Pluvicto at its radioligand therapy production sites in Ivrea, Italy, and Milburn, New Jersey, affecting both commercial and clinical trial supply. (SNMMI News) May 4, 2022 — Active Brown Adipose Tissue Protects Against “Pre-Prediabetes” In a prospective study of young, lean adults, PET/CT imaging revealed that higher levels of active brown adipose tissue (also known as “brown fat”) are more prevalent in individuals who exhibit very early indications of metabolic disorders. The research was published ahead of print in The Journal of Nuclear Medicine. (Press Releases) April 29, 2022 — JNM Publishes Joint Guide for the Establishment of Theranostics Centers SNMMI, the European Association of Nuclear Medicine, and the International Atomic Energy Agency have created a new guide for the creation of dedicated theranostics centers. (Press Releases) April 28, 2022 — SNMMI and Partners Request a Hearing for the FIND Act This week, SNMMI and over 70 organizations sent a letter to House Energy and Commerce and Ways and Means Committee Leadership requesting a hearing on the Facilitating Innovative Nuclear Diagnostics (FIND) Act. (Government Relations News) April 21, 2022 — Novel Deep Learning Method Provides Early and Accurate Differential Diagnosis for Parkinsonian Diseases A new deep learning method has been created to aid in the diagnosis of parkinsonian diseases, according to research published in JNM. (Press Releases) April 12, 2022 — New ASNC/SNMMI Training Course Helps Physicians Meet U.S. Requirements for Handling Medical Radioisotopes SNMMI and ASNC have released a new “80 Hour Radionuclide Authorized User Training Course” for nuclear medicine physicians, which will fulfill the 80 hours of classroom training required by the NRC and Agreement States for physicians to become Authorized Users. (Press Releases) April 11, 2022 — DOE Announces $1 million in Funding for Radioisotope Research On April 11, the U.S. Department of Energy (DOE) announced $1 million in funding for isotope development. (SNMMI News) April 8, 2022 — SNMMI Releases Statement on CMS Final Decision for Alzheimer’s Disease Coverage CMS has announced its final decision on coverage of monoclonal antibodies to treat Alzheimer’s disease. It includes no additional coverage for beta amyloid PET scans, which will continue to be limited to one per patient per lifetime. (Press Releases) CONTINUING EDUCATION New! ASNC/SNMMI 80 Hour Authorized User Training Course The new online ASNC/SNMMI 80 Hour Authorized User Training Course is designed to provide nuclear medicine physicians with the knowledge needed to establish a culture of safety and quality in their practice. Learn More »New! SNMMI Qualified Systems Personnel Training Program (QSPTP)The SNMMI Qualified Systems Personnel Training Program (QSPTP) has been developed to define the competencies of a Qualified Person in the release of manufactured radiopharmaceuticals, providing experts in the field of radiopharmaceutical science guidance in program development. Learn More »SNMMI WebinarsAccess upcoming and recorded webinars from the new SNMMI Webinars website. Learn More »Nuclear Medicine Online Review CourseCovering the most essential topics in nuclear medicine—you'll build the level of expertise you need to ace your exam! AMA PRA Category 1 credits available. Learn More »Radiation Safety+ Review and EssentialsThe Radiation Safety+ Review and Essentials program provides a comprehensive overview of all aspects of radiation safety for nuclear medicine technologists preparing to take the NMTCB’s Radiation Safety Certification Examination. Learn More »CT+ Review and EssentialsCT+ Review and Essentials provides you with the comprehensive didactic education you need to succeed, whether you're looking to build your general CT knowledge, or preparing to sit for the ARRT (CT) and/or NMTCB (CT) exam(s). Learn More »Member Benefit! Complimentary Journal SAMs/Journal CEFree Journal SAM/CE access is available exclusively for SNMMI Members. Take advantage of this great benefit and meet your certification requirements. Learn more » PUBLICATIONSJournal of Nuclear MedicineVIEW CURRENT ISSUEJournal of Nuclear Medicine TechnologyVIEW CURRENT ISSUEMolecular Imaging JournalVIEW CURRENT ISSUE FEDERAL LEGISLATIVE EFFORTSThe FIND Act – Learn more »MOLECULAR IMAGING NEWS May 5, 2022 Joint guide for creation of theranostics centers published COVID-19 pandemic led to drop in V/Q scans Serine supplements may not protect against AD, study finds Sign up for SNMMI SmartBrief »FEATURED VIDEOAttend the SNMMI 2022 Annual MeetingJune 11-14 | Vancouver, BCWatch these special messages from SNMMI Scientific Program chair, Heather Jacene, MD, about all the great things happening in Vancouver this June at the #SNMMI22 Annual Meeting! You don't want to miss it. Register now. Subscribe to SNMMI's YouTube channel.UPCOMING EVENTS22nd International Conference on Nephrology and UrologyMay 6 –7, 2022| Barcelona, Spain| This event will discuss about the treatment advances in Nephrology and Urology.See Event Details ►3rd Annual Nuclear Medicine Resident ReviewMay 7, 2022See Event Details ►BNMS Spring Meeting 2022May 16 –18, 2022| Glasgow, Scotland| Highlights include: Bootcamp including Cardiac workshop Dedicated Radiographer, Technologist and Nurse Sessions Research Session PET-CT Masterclasses Theragnostics PRRT registry workshop Dementia Imaging Quantification in Nuclear Medicine SPECT-CT masterclass MRT training whole day series An Inspector calls Non-medical reporting Accreditation Radioisotope supply Therapy sessions Registration is now open! Abstract submission is still open!See Event Details ► SOCIAL MEDIASNMMI on TwitterFeatured Jobs Tweets by SNM_MIFeatured Jobs from SNMMI's Career Center Visit SNMMI's Career Center » EDUCATION AND RESEARCH FOUNDATION ERF secures, invests and distributes funding to support rigorously vetted physicians, scientists and technologists in the pursuit of advanced academic studies or breakthrough discoveries in the field. Learn More » ADVERTISING • LIST SALES • MEDIA • CONTACT • SITE MAP • PRIVACY NOTICE/LEGAL/DISCLAIMER COI• REPORT A PROBLEM 1850 Samuel Morse Drive  Reston, Virginia 20190  P: 703.708.9000  F: 703.708.9015 Download Acrobat ReaderSTAY IN TOUCH: